Related Experiment Video
Updated: Aug 4, 2026
09:01
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis
H K Janai1, H R Stutman, M Zaleska
1Division of Pediatric Infectious Diseases, Memorial Miller Children's Hospital, Long Beach, CA 90801-1428.
The Pediatric Infectious Disease Journal
|March 1, 1993
Summary
Ribavirin did not improve pulmonary function in infants with respiratory syncytial virus (RSV) bronchiolitis. While compliance increased significantly with ribavirin by Day 7, this did not translate to improved lung function.
Area of Science:
- Pediatrics
- Pulmonology
- Infectious Diseases
Background:
- Respiratory syncytial virus (RSV) bronchiolitis is a common pediatric respiratory infection.
- Ribavirin has been investigated for its potential therapeutic effects in RSV infections.
- Pulmonary function changes in infants with RSV bronchiolitis are not fully understood.
Purpose of the Study:
- To evaluate the impact of aerosolized ribavirin on pulmonary function in infants diagnosed with RSV bronchiolitis.
- To determine if ribavirin treatment leads to measurable improvements in dynamic compliance and total lung resistance.
- To investigate whether observed clinical improvements with ribavirin are associated with enhanced lung function.
Main Methods:
- A randomized, double-blind, placebo-controlled study involving 19 infants with RSV bronchiolitis.
- Exclusion of infants with pre-existing respiratory, cardiac, or immunologic conditions.
- Administration of ribavirin or placebo via aerosol for 18 hours/day over 3 days.
- Measurement of pulmonary function, including dynamic compliance and total lung resistance, using pneumotachography on Days 1, 2, and 7.
Main Results:
- No significant differences in clinical criteria were observed between the ribavirin and placebo groups.
- Approximately 50% of infants in both groups showed improved compliance and reduced lung resistance within 24-48 hours.
- By Day 7, dynamic compliance increased by 30% in the placebo group and 210% in the ribavirin group (P=0.05).
- No significant differences in the rate of change of total lung resistance were detected by Day 7.
Conclusions:
- Improvements in the early clinical course of RSV bronchiolitis treated with ribavirin do not appear to be mediated by significant changes in measurable pulmonary function.
- Ribavirin treatment did not result in paradoxical increases in airway resistance.
- Further research may be needed to elucidate the mechanisms behind any observed clinical benefits of ribavirin in RSV bronchiolitis.
Related Concept Videos
01:19Factors Affecting Pulmonary Ventilation
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...